1. New surveillance guidelines for Li-Fraumeni and hereditary TP53 related cancer syndrome: implications for germline TP53 testing in breast cancer

   • D. Gareth Evans
   • Emma R. Woodward

   Editorial 28 September 2020 Pages: 1 - 7

   

2. The CAPP II trial of aspirin in Lynch syndrome/HNPCC: is it time for everyone to be treated?

   • Patrick M. Lynch

   Editorial Comment 09 January 2021 Pages: 9 - 11

3. Improving primary care identification of familial breast cancer risk using proactive invitation and decision support

   • Nadeem Qureshi
   • Brittany Dutton
   • Joe Kai

   Original Article Open access 11 June 2020 Pages: 13 - 21

   

4. Chemoprevention in familial adenomatous polyposis: past, present and future

   • Phillip M. Kemp Bohan
   • Gautam Mankaney
   • Carol A. Burke

   Review 08 June 2020 Pages: 23 - 33

5. Prospective observational data informs understanding and future management of Lynch syndrome: insights from the Prospective Lynch Syndrome Database (PLSD)

   • Toni T. Seppälä
   • Mev Dominguez-Valentin
   • Pål Møller

   Review Open access 08 June 2020 Pages: 35 - 39

6. Low accuracy of self-reported family history of melanoma in high-risk patients

   • Nicholas D. Flint
   • Michael D. Bishop
   • Aaron M. Secrest

   Original Article 21 May 2020 Pages: 41 - 48

   

7. Small fraction of testicular cancer cases may be causatively related to CHEK2 inactivating germ-line mutations: evidence for somatic loss of the remaining CHEK2 allele in the tumor tissue

   • Valeriya I. Ni
   • Alexandr O. Ivantsov
   • Evgeny N. Imyanitov

   Original Article 26 May 2020 Pages: 49 - 53

8. Two cases of somatic STK11 mosaicism in Danish patients with Peutz–Jeghers syndrome

   • Anne Marie Jelsig
   • Birgitte Bertelsen
   • John Gásdal Karstensen

   Short Communication 06 June 2020 Pages: 55 - 59

   

9. Germline variants discovered in lymphoma patients undergoing tumor profiling: a case series

   • Anthony J. Scott
   • Molly C. Tokaz
   • Ryan A. Wilcox

   Original Article 06 June 2020 Pages: 61 - 65

10. Report of the fifth meeting of the European Consortium 'Care for CMMRD' (C4CMMRD), Leiden, The Netherlands, July 6th 2019

    • M. Suerink
    • K. Wimmer
    • H. F. A. Vasen

    Review Open access 02 July 2020 Pages: 67 - 73

11. Complete response of hereditary leiomyomatosis and renal cell cancer (HLRCC)-associated renal cell carcinoma to nivolumab and ipilimumab combination immunotherapy by: a case report

    • Yasuhiro Iribe
    • Mitsuko Furuya
    • Noboru Nakaigawa

    Short Communication 15 July 2020 Pages: 75 - 80

    

12. Multiple primary cancers (renal papillary, lymphoma and teratoma) and hepatic cysts in association with a pathogenic germline mutation in the MET gene

    • Julian Adlard

    Short Communication 20 July 2020 Pages: 81 - 83